Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New lung camera could replace needle biopsies

NCT ID NCT02961335

Knowledge-focused Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to see if a tiny camera on a thin tube (bronchoscopy) could help doctors diagnose diffuse lung diseases without needing a surgical lung biopsy. The camera takes live microscopic images of the air sacs. The study was stopped early, but it involved 38 adults with conditions like pulmonary fibrosis or sarcoidosis. The goal was to see if certain patterns in the images could reliably point to the right diagnosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

38 people

The number who actually took part.

Started

Dec 2018

Finished

Sep 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age ≥ 18 * signed written informed consent * indication for a flexible bronchoscopy * DPLD characterized by clinical and radiological data compatible with : idiopathic pulmonary fibrosis (IPF), acute or chronic hypersensitivity pneumonitis (HPS), sarcoidosis, or asbestosis. * Initial histological confirmation of the disease is not required for the inclusion of the patient and the realisation of the alveolar bronchoscopy. * non-smoking or smoking cessation \>6 month * Patient affiliated with, or beneficiary of a social security category Exclusion Criteria: * respiratory failure and contraindication for a flexible bronchoscopy (this item will stay at the appreciation of the physician, arterial blood gaz sampling being not required) * bleeding disorder which would be not compatible with the realization of a flexible bronchoscopy * history of pneumonectomy or non functional lung controlateral to the pCLE procedure * patients for which a per-endoscopic distal lung cryobiopsy is forecasted during the first diagnostic bronchoscopy, * patients for which the bronchoscopy needs a general anesthesia and mechanical ventilation during the procedure * anticoagulant or platelet aggregation inhibitors that cannot be interrupted for the flexible bronchoscopy * patients for which a follow up or an adequate work-up to achieve the final diagnosis will not be possible. * patients for which a cryobiopsy is forecasted during the bronchoscopy * pregnant and breast feeding women, or women of childbearing potential not taking adequate contraception * Patients unable to understand informed consent * Patient on major legal measure of protection * Patients participating in an other interventional clinical trial at the inclusion date

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asbestosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

asbestosis hypersensitivity pneumonitis idiopathic pulmonary fibrosis interstitial lung disease sarcoidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diffuse parenchymal lung diseases

Contacts and locations

Locations

  • Rouen University Hospital

    Rouen, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.